Experimental Autoimmune Encephalomyelitis Complementary Peptide

Experimental Autoimmune Encephalomyelitis Complementary Peptide is a 11-residue synthetic peptide with the sequence Val-Phe-Ile-Leu-Gly-Pro-Leu-Arg-Leu-Leu-Gly. The sequence has a relatively high hydrophobic-residue fraction that can influence aqueous solubility and surface adsorption. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence.

• LC-MS/HPLC analytical method development
• sequence-specific assay controls

Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions.